Reproductive Outcomes After Gestational Trophoblastic Neoplasia. A Comparison Between Single-Agent and Multiagent Chemotherapy-Reference-Cited by-同舟云学术

Reproductive Outcomes After Gestational Trophoblastic Neoplasia. A Comparison Between Single-Agent and Multiagent Chemotherapy

Published:2018-02 Issue:2 Volume:28 Page:332-337
ISSN:1048-891X
Container-title:International Journal of Gynecological Cancer
language:en
Short-container-title:International Journal of Gynecological Cancer

Author:

Cioffi Raffaella,Bergamini Alice,Gadducci Angiolo,Cormio Gennaro,Giorgione Veronica,Petrone Micaela,Rabaiotti Emanuela,Pella Francesca,Candiani Massimo,Mangili Giorgia

Publisher

BMJ

Subject

Obstetrics and Gynaecology,Oncology

Reference22 articles.

1. Update on the diagnosis and management of gestational trophoblastic disease

2. Trophoblastic Disease Review for Diagnosis and Management: A Joint Report From the International Society for the Study of Trophoblastic Disease, European Organisation for the Treatment of Trophoblastic Disease, and the Gynecologic Cancer InterGroup

3. Gestational trophoblastic disease

4. Secondary chemotherapy for high-risk gestational trophoblastic neoplasia

5. Role of surgical therapy in the management of gestational trophoblastic neoplasia

Cited by 17 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Maximizing ovarian function and fertility following chemotherapy in premenopausal patients: Is there a role for ovarian suppression?;Gynecologic Oncology Reports;2024-06

2. Choriocarcinoma After Term Pregnancy With a Subsequent Successful Pregnancy: A Rare Entity;Cureus;2023-10-24

3. Fertility-Sparing Treatment in Gestational Choriocarcinoma: Evaluating Oncological and Obstetrical Outcomes in Young Patients;Medical Science Monitor;2023-09-23

4. Effect of actinomycin D on ovarian reserve in low-risk gestational trophoblastic neoplasia;International Journal of Gynecologic Cancer;2023-06-08

5. Management of trophoblastic tumors : review of evidence, current practice, and future directions;Expert Review of Anticancer Therapy;2023-05-22